Non-prescription medicines
Non-prescription medicines can be purchased without a prescription from a doctor or other health professional.
Non-prescription medicines can be bought off the shelf from supermarkets, health food shops or over the counter from pharmacies, depending on their level of risk.
Non-prescription medicines are entered on the Australian Register of Therapeutic Goods (ARTG) as either listed, assessed listed or registered medicines. This is based on their level of risk to the consumer, determined by the ingredients they contain and their intended use (therapeutic indications).
All non-prescription medicines must be manufactured in a licensed or approved facility according to good manufacturing practice (GMP) principles.
Some non-prescription medicines are commonly referred to as complementary medicines.
Listed medicines
- Lowest risk non-prescription medicines.
- Have ‘AUST L’ on the label.
- Not individually evaluated by the TGA for quality, safety and efficacy before they are supplied in the marketplace.
- Ingredients are selected from a TGA pre-approved ingredients list.
- More information about listed medicines.
Assessed listed medicines
- Lower risk non-prescription medicines.
- Have ‘AUST L(A)’ on the label.
- Therapeutic indications have been assessed by the TGA for efficacy before they are supplied in the marketplace.
- Ingredients are selected from a TGA pre-approved ingredients list.
- Can use the ‘TGA assessed’ claim on their label.
- More information about assessed listed medicines.
Registered non-prescription medicines
- Higher risk non-prescription medicines.
- Have ‘AUST R’ on the label.
- TGA performs a full pre-market evaluation of their safety, quality and efficacy before they are supplied in the market.
- Two main types of registered non-prescription medicines:
- Over the counter (OTC) medicines, such as pain relief, antihistamines, nicotine replacement therapy.
- Registered complementary medicines, such as higher dose iron supplements.
- Registered complementary medicines can use the ‘TGA assessed’ claim on their label.
Latest alerts
-
The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
We have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
-
Kin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.
Latest articles
-
Consent relating to listed medicines that contain whole live microorganisms as an active ingredient
This consent is given under sections 14 and 14A of the Therapeutic Goods Act 1989. -
Elemental impurities in traditional Chinese medicines (TCMs)
TCMs sold in Australia are carefully regulated to ensure safety and quality. -
Automatic extension of Mutual Recognition Agreement (MRA) Good Manufacturing Practice (GMP) clearances
MRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
Latest publications
-
Advisory Committee on Complementary Medicines meeting statement for 14 March 2024
-
We commissioned the Health Design Lab to conduct market research to better understand the individual consumer, pharmacist and prescriber experiences of shortages and discontinuations.
-
Interim decisions and invitation for further comment. Closing date: 3 March 2023